Breast intervention during late pregnancy to reduce engorgement and stress
Effects of Breast Tenderness Relief Intervention During the Late Pregnancy on the Parturients' Breast Engorgement, Lactation, Breastfeeding, Maternal Competence, and Stress
This study is testing a new way to help pregnant women in their last weeks feel less breast tenderness and stress to see if it improves their breastfeeding experience and overall well-being.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 180 (estimated) |
| Ages | 20 Years and up |
| Sex | Female |
| Sponsor | National Defense Medical Center, Taiwan Academic / other |
| Locations | 1 site (Taipei) |
| Trial ID | NCT05796284 on ClinicalTrials.gov |
What this trial studies
This study examines the effects of a breast tenderness relief intervention on pregnant women during the late stages of pregnancy. It aims to alleviate breast engorgement, enhance lactation, and improve maternal competence and stress levels. The study will involve 180 participants who will be randomly assigned to receive either routine care or the intervention from the 36th week of pregnancy until three months postpartum. Data will be collected through questionnaires and biological measurements at various points during and after pregnancy to assess the outcomes.
Who should consider this trial
Good fit: Ideal candidates are healthy pregnant women over 20 years old, at least 36 weeks pregnant, and able to communicate in Chinese or Taiwanese.
Not a fit: Patients with mental illness, significant maternal complications, or those unable to breastfeed may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve breastfeeding experiences and maternal well-being for new mothers.
How similar studies have performed: Other studies have shown positive outcomes with similar interventions aimed at improving breastfeeding experiences, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1. Healthy pregnant women over 20 years old, without mental illness, and the number of pregnancy weeks has reached 36 weeks; 2. Full term production; 3. Literate or able to communicate in Chinese and Taiwanese; 4. After explaining, agree to participate in the research, sign the consent form, and accept long-term follower Exclusion Criteria: 1. Pregnant women with a history of smoking, alcohol, and drug abuse; 2. Pregnant women have mental illness; 3. Maternal complications during childbirth or postpartum, such as: postpartum hemorrhage, infection, etc.; 4. Newborns with congenital abnormalities and major diseases; 5. Pregnant women who are unable or unwilling to breastfeed due to illness or other factors; 6. Refuse to accept breast compression intervention will be excluded from participating in the study
Where this trial is running
Taipei
- National defense medical center — Taipei, Taiwan (Recruiting)
Study contacts
- Study coordinator: Lan Hsiang-Yun, A.P.
- Email: shinnylan@msn.com
- Phone: +886287923100
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.